Key Points
- Director Debra Schwartz sold 4,200 shares on Dec. 11 at an average price of $83.59 for about $351,078, leaving her with 21,567 shares (a 16.3% reduction) as disclosed in an SEC filing.
- Lemonade reported last-quarter EPS of -$0.51, beating estimates (-$0.72) with revenue of $194.5 million (up 42.4% year-over-year), but still shows negative ROE (31.86%) and a net margin of -26.39%.
- The stock trades with a market cap of $5.62 billion and a 52-week range of $24.31–$84.52, while analysts hold a consensus rating of "Hold" with a $58.57 target and mixed individual ratings.
Lemonade, Inc. (NYSE:LMND - Get Free Report) Director Debra Schwartz sold 4,200 shares of the business's stock in a transaction that occurred on Thursday, December 11th. The stock was sold at an average price of $83.59, for a total value of $351,078.00. Following the sale, the director directly owned 21,567 shares in the company, valued at approximately $1,802,785.53. The trade was a 16.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Lemonade Stock Performance
LMND opened at $75.16 on Tuesday. The company has a market capitalization of $5.62 billion, a PE ratio of -31.45 and a beta of 2.13. The stock's fifty day moving average is $66.10 and its 200-day moving average is $53.72. Lemonade, Inc. has a one year low of $24.31 and a one year high of $84.52.
Lemonade (NYSE:LMND - Get Free Report) last released its earnings results on Wednesday, November 5th. The company reported ($0.51) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.72) by $0.21. Lemonade had a negative return on equity of 31.86% and a negative net margin of 26.39%.The firm had revenue of $194.50 million for the quarter, compared to analyst estimates of $185.06 million. During the same period in the previous year, the company earned ($0.95) earnings per share. Lemonade's revenue was up 42.4% compared to the same quarter last year. On average, equities research analysts forecast that Lemonade, Inc. will post -3.03 EPS for the current fiscal year.
Hedge Funds Weigh In On Lemonade
Several hedge funds have recently bought and sold shares of LMND. Titleist Asset Management LLC lifted its position in shares of Lemonade by 4.1% in the third quarter. Titleist Asset Management LLC now owns 4,832 shares of the company's stock worth $259,000 after buying an additional 189 shares during the last quarter. Ameritas Investment Partners Inc. lifted its holdings in Lemonade by 4.0% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 5,683 shares of the company's stock worth $249,000 after purchasing an additional 220 shares during the last quarter. CWM LLC boosted its position in Lemonade by 9.9% during the third quarter. CWM LLC now owns 2,518 shares of the company's stock worth $135,000 after purchasing an additional 227 shares during the period. Migdal Insurance & Financial Holdings Ltd. grew its holdings in Lemonade by 30.7% during the second quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,034 shares of the company's stock valued at $45,000 after purchasing an additional 243 shares during the last quarter. Finally, Watershed Private Wealth LLC grew its holdings in Lemonade by 4.9% during the third quarter. Watershed Private Wealth LLC now owns 8,170 shares of the company's stock valued at $437,000 after purchasing an additional 380 shares during the last quarter. 80.30% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of analysts recently weighed in on the stock. Citizens Jmp raised their target price on shares of Lemonade from $60.00 to $80.00 and gave the stock a "market outperform" rating in a report on Monday, November 24th. Morgan Stanley raised their price objective on shares of Lemonade from $49.00 to $53.00 and gave the stock an "underweight" rating in a research note on Monday, November 17th. Weiss Ratings reissued a "sell (d-)" rating on shares of Lemonade in a research note on Wednesday, October 8th. BMO Capital Markets increased their target price on Lemonade from $23.00 to $42.00 and gave the company an "underperform" rating in a report on Monday, August 18th. Finally, Keefe, Bruyette & Woods lifted their price target on Lemonade from $35.00 to $40.00 and gave the company an "underperform" rating in a report on Tuesday, November 25th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has given a Hold rating and four have issued a Sell rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $58.57.
View Our Latest Report on LMND
About Lemonade
(
Get Free Report)
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
